Cyber Business Interruption and the Impact on the Pharmaceutical and Manufacturing Industry

Holland & Knight, Beecher Carlson and CFC Underwriting invite you to our in-depth webinar presentation, "Cyber Business Interruption and the Impact on the Pharmaceutical and Manufacturing Industry."

While the cyber headlines continually report on the latest data breaches, the potentially biggest loss has nothing to do with privacy. Rather, the past year has featured an abundance of examples of the substantial costs involved with business interruption, extra expense and supply chain interruption caused by cyberattacks.

Perhaps none is more illustrative than the estimated $1 billion loss Merck suffered because of the NotPetya cyberattack. It was an operational nightmare – disrupting not only manufacturing but research and sales as well. The insurance market, particularly the property market, is taking pause. What is the intent of their existing coverage for cyber-related losses, and how will they manage coverage going forward?

Our presenters will discuss ways to:

• identify the interaction between product, property, cyber and other insurance policies
• pinpoint exposures, including supply chain and other vulnerabilities
• implement or revise a program to effectively cover cyber risks

Speakers:

Thomas Bentz Jr.
Partner | Holland & Knight

Mr. Bentz practices insurance law with a focus on directors and officers (D&O), cyber, and other management liability insurance policies. He and his team provide insight and guidance on ways to improve policy language and help insureds maximize their possible insurance recovery.

Jeffrey Mittleman
Partner | Holland & Knight

Mr. Mittleman is co-leader of the Healthcare & Life Sciences Industry Group and a member of the Compliance Services Team. He has published several articles and spoken at conferences regarding various health law issues, including compliance, fraud and abuse, pharmacy law, drug distribution and managed care.